Showing results (541-550 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|May 24, 2022
Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?Mariana Boulos, Elissar Moujaes, Ghazi Nsouli, et al.
Pharmacogenomics|May 26, 2022
NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicityNur Farhana Mohamed Noor, Mohd Zaki Salleh, Mohd Arif Mohd Zim, et al.
Pharmacogenomics|December 25, 2007
Pharmacogenetics of the constitutive androstane receptorJatinder K Lamba
Pharmacogenomics|February 29, 2008
Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixtureRita C E Estrela, Fábio S Ribeiro, Renato S Carvalho, et al.
Pharmacogenomics|February 29, 2008
Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population studySheldon C Cooper, Loretta T Ford, Jonathan D Berg, et al.
Pharmacogenomics|June 4, 2008
Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancerDaniel Vallböhmer, Elmar Kuhn, Ute Warnecke-Eberz, et al.
Pharmacogenomics|June 4, 2008
Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland ChinaLingling Chen, Shengying Qin, Jing Xie, et al.
Pharmacogenomics|June 4, 2008
Current trends in N-acetyltransferase research arising from the 2007 International NAT WorkshopSotiria Boukouvala, Isaac M Westwood, Neville J Butcher, et al.
Pharmacogenomics|January 19, 2021
Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparisonDyson T Wake, Gillian C Bell, David B Gregornik, et al.
Pharmacogenomics|September 28, 2019
Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variantsSenthilkumar Sadhasivam, Barbara W Brandom, Richard A Henker, et al.
Pageof 274